NCT06750510 Digital Universal Parenting Program for Positive Parenting Behaviors
| NCT ID | NCT06750510 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Turku |
| Condition | Parenting |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,500 participants |
| Start Date | 2022-01-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,500 participants in total. It began in 2022-01-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to evaluate use and feasibility of digitally-delivered universal parenting program, which aims to promote positive parenting among guardians with 3 years-old children.
Eligibility Criteria
Inclusion Criteria: * Guardians having a child aged 3 years participating to annual health checkup in child health clinic. * At least one of the guardians is able to understand the languages that intervention is provided in Exclusion Criteria: * Inability to read Finnish, Swedish, or English, as these are the languages that the intervention is provided in. * No internet access
Contact & Investigator
Andre Sourander, Professor, MD
STUDY DIRECTOR
University of Turku
Frequently Asked Questions
Who can join the NCT06750510 clinical trial?
This trial is open to participants of all sexes, studying Parenting. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06750510 currently recruiting?
Yes, NCT06750510 is actively recruiting participants. Contact the research team at kaemka@utu.fi for enrollment information.
Where is the NCT06750510 trial being conducted?
This trial is being conducted at Turku, Finland, Turku, Finland.
Who is sponsoring the NCT06750510 clinical trial?
NCT06750510 is sponsored by University of Turku. The principal investigator is Andre Sourander, Professor, MD at University of Turku. The trial plans to enroll 1,500 participants.